1
|
Yamaguchi Y, Uchimura K, Takahashi K, Ishii T, Hanai S, Furuya F. Hyperthyroidism exacerbates ischemic reperfusion injury in the kidney. Endocr J 2022; 69:263-272. [PMID: 34629337 DOI: 10.1507/endocrj.ej21-0395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Thyroid hormones are critical regulators of vertebrate development and metabolism. Under hyperthyroid conditions, excess thyroid hormones induce expression of several enzymes and activities via activation of ligand-bound thyroid hormone receptors (TRs). Arginase (ARG) is downstream of a ligand-bound TR and overexpression of ARG2 induces the production of reactive oxygen species and subsequent exacerbation of kidney ischemia/reperfusion (I/R) injury. To clarify the association between I/R-induced kidney injury and hyperthyroidism, mice were pretreated with L-thyroxine (LT4) or vehicle alone, then subjected to I/R. Proximal tubular cell-specific conditional knockout of thyroid hormone receptor β (TRβcKO) mice was generated and the effects of I/R were analyzed. Hyperthyroidism enhanced tubular damage and fibrosis in the kidneys of mice after I/R. Hyperthyroidism induced tubular cell necroptosis following inflammatory cell accumulation in the kidney after I/R. ARG2 expressions and reactive oxygen species accumulated in the kidneys of hyperthyroid mice after I/R, but these changes were ameliorated in the kidneys of TRβcKO mice. Hyperthyroidism-enhanced kidney injury was ameliorated in the kidney of TRβcKO mice after I/R. These results suggest that excess thyroid hormones are disadvantageous for the kidney under ischemic stress. Overt hypothyroidism represents a severe thyroid hormone deficiency disease that requires LT4 treatment, while overreplacement or iatrogenic thyrotoxicosis might cause kidney injury.
Collapse
Affiliation(s)
- Yasuno Yamaguchi
- Division of Nephrology, Department of Internal Medicine, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Yamanashi 409-3898, Japan
| | - Kohei Uchimura
- Division of Nephrology, Department of Internal Medicine, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Yamanashi 409-3898, Japan
| | - Kazuya Takahashi
- Division of Nephrology, Department of Internal Medicine, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Yamanashi 409-3898, Japan
| | - Toshihisa Ishii
- Division of Nephrology, Department of Internal Medicine, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Yamanashi 409-3898, Japan
| | - Shunichiro Hanai
- Division of Rheumatology, Department of Internal Medicine, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Yamanashi 409-3898, Japan
| | - Fumihiko Furuya
- Division of Nephrology, Department of Internal Medicine, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Yamanashi 409-3898, Japan
| |
Collapse
|
2
|
Toral M, Jimenez R, Montoro-Molina S, Romero M, Wangensteen R, Duarte J, Vargas F. Thyroid hormones stimulate L-arginine transport in human endothelial cells. J Endocrinol 2018; 239:49–62. [PMID: 30307153 DOI: 10.1530/joe-18-0229] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Thyroid hormone activity is associated with L-arginine metabolism and nitric oxide (NO) production, which participate in the cardiovascular manifestations of thyroid disorders. L-arginine transporters play an important role in activating L-arginine uptake and NO production. However, the effects of thyroid hormones on L-arginine transporters in endothelial cells have not yet been evaluated. The following methods were used. We measured L-arginine uptake, mRNA expression of L-arginine transporters, endothelial nitric oxide synthase (eNOS) mRNA and NO generation after the administration of T3, T4 and the T3 analog, 3,3′,5-triiodothyroacetic acid TRIAC in human umbilical vein endothelial cells (HUVECs). We also analyzed the role of αvβ3 integrin and of phosphatidyl-inositol-3 kinase (PI3K), mitogen-activated protein kinases (MAPKs: ERK1/2, p38 and SAPK-JNK) and intracellular calcium signaling pathways as underlying mechanisms. To this end, αvβ3 integrin was pharmacologically inhibited by tetraiodothyroacetic acid (TETRAC) or genetically blocked by silencing αv mRNA and PI3K, MAPKs and intracellular calcium by selective inhibitors. The following results were obtained. Thyroid hormones and the T3 analog TRIAC increased L-arginine uptake in HUVECs, the sodium-independent y+/CAT isoforms, except CAT2b, sodium-dependent y+L system and sodium-independent system b0,+L-arginine transporters, eNOS mRNA and NO production. These effects were suppressed by αvβ3 integrin inhibition with TETRAC or αv integrin downregulation or by PI3K, MAPK or intracellular Ca2+ signaling inhibitors. In conclusion, we report for the first time that activation of L-arginine uptake by thyroid hormones is related to an upregulation of L-arginine transporters. This effect seems to be mediated by activation of αvβ3 integrin receptor and subsequent PI3K, MAPK and intracellular Ca2+ signaling pathways.
Collapse
Affiliation(s)
- Marta Toral
- Departamento de Farmacología, Facultad de Farmacia, Granada, Spain
| | - Rosario Jimenez
- Departamento de Farmacología, Facultad de Farmacia, Granada, Spain
- Instituto de Investigación Biosanitaria GRANADA, Hospitales Universitarios de Granada, Universidad de Granada, Granada, Spain
| | | | - Miguel Romero
- Departamento de Farmacología, Facultad de Farmacia, Granada, Spain
- Instituto de Investigación Biosanitaria GRANADA, Hospitales Universitarios de Granada, Universidad de Granada, Granada, Spain
| | | | - Juan Duarte
- Departamento de Farmacología, Facultad de Farmacia, Granada, Spain
- Instituto de Investigación Biosanitaria GRANADA, Hospitales Universitarios de Granada, Universidad de Granada, Granada, Spain
| | - Félix Vargas
- Instituto de Investigación Biosanitaria GRANADA, Hospitales Universitarios de Granada, Universidad de Granada, Granada, Spain
- Departamento de Fisiología, Facultad de Medicina, Granada, Spain
| |
Collapse
|
3
|
Liu M, Li Z, Liang B, Li L, Liu S, Tan W, Long J, Tang F, Chu C, Yang J. Hydrogen sulfide ameliorates rat myocardial fibrosis induced by thyroxine through PI3K/AKT signaling pathway. Endocr J 2018; 65:769-781. [PMID: 29743447 DOI: 10.1507/endocrj.ej17-0445] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
This study aims to investigate the role and regulatory mechanism of the Hydrogen sulfide (H2S) in amelioration of rat myocardial fibrosis induced by thyroxine through interfering the autophagy via regulating the activity of PI3K/AKT1 signaling pathway and the expression of relative miRNA. 40 adult male SD rats were randomly divided into 4 groups (n = 10): the control group, the thyroxine model group (TH group), the model group with H2S intervention (TH + H2S group) and the normal group with H2S intervention (H2S group). Pathological changes were observed via H&E staining and Masson staining, Expressions of MMPs/TIMPs, PI3K/AKT, autophagy-related proteins in myocardial tissues were detected via Western blotting, and the expressions of miR-21, miR-34a, miR-214 and miR-221 were detected via RT-qPCR. Compared with the control group, in the TH group, myocardial fibrosis was more significant, the expressions of proteins in PI3K/AKT and autophagy-related proteins were significantly decreased, as well as the expression of miR-221; while the expressions of miR-21, miR-34a and miR-214 were significantly elevated. By contrast, all above-mentioned changes were obviously reversed with H2S treatment, which demonstrated the positive function of H2S in amelioration of rat myocardial fibrosis induced by thyroxine. The mechanism of such amelioration may be correlated with autophagy activated by the upregulation of expression of PI3K/AKT signaling pathway and downregulation of expressions of miR-21, miR-34a and miR-214.
Collapse
Affiliation(s)
- Maojun Liu
- Department of Cardiology, the First Affiliated Hospital of University of South China, Hunan 421001, China
| | - Zining Li
- Department of Cardiology, the First Affiliated Hospital of University of South China, Hunan 421001, China
| | - Biao Liang
- Department of Cardiology, the First Affiliated Hospital of University of South China, Hunan 421001, China
| | - Ling Li
- Department of Cardiology, the First Affiliated Hospital of University of South China, Hunan 421001, China
| | - Shengquan Liu
- Department of Cardiology, the First Affiliated Hospital of University of South China, Hunan 421001, China
| | - Wenting Tan
- Department of Cardiology, the First Affiliated Hospital of University of South China, Hunan 421001, China
| | - Junrong Long
- Department of Cardiology, the First Affiliated Hospital of University of South China, Hunan 421001, China
| | - Fen Tang
- Department of Cardiology, the First Affiliated Hospital of University of South China, Hunan 421001, China
| | - Chun Chu
- Department of Pharmacy, the Second Affiliated Hospital of University of South China, Hunan 421001, China
| | - Jun Yang
- Department of Cardiology, the First Affiliated Hospital of University of South China, Hunan 421001, China
| |
Collapse
|
4
|
Ding LY, Chen LM, Wang MZ, Zhang J, Loor JJ, Zhou G, Zhang X, Wang HR. Inhibition of arginase via jugular infusion of N ω-hydroxy-nor-l-arginine inhibits casein synthesis in lactating dairy cows. J Dairy Sci 2018; 101:3514-3523. [PMID: 29397169 DOI: 10.3168/jds.2017-13178] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2017] [Accepted: 11/28/2017] [Indexed: 01/04/2023]
Abstract
A previous in vitro study revealed that Arg elicits positive effects on casein synthesis through alterations of the Arg-ornithine pathway in bovine mammary epithelial cells. The main purpose of this work was to determine the effects of arginase inhibition using Nω-hydroxy-nor-l-arginine (nor-NOHA) on milk protein synthesis in vivo. Six healthy Chinese Holstein cows with similar body weight (550.0 ± 20 kg; means ± standard deviation), parity (4), body condition score (3.0), milk yield (21.0 ± 1.0 kg), and days in milk (80 ± 2) were selected and randomly assigned to 3 treatments in a replicated 3 × 3 Latin square design with 22 d for each period (7 d for infusion and 15 d for washout). The treatments were (1) control: saline infusion; (2) nor-NOHA: infusion of 125 mg/L of nor-NOHA; (3) nor-NOHA + Arg: infusion of 125 mg/L of nor-NOHA with 9.42 g/L of Arg. The activity of enzymes related to Arg metabolism, milk protein synthesis, and expression of AA transporters was determined. The infusion of nor-NOHA decreased the activity of arginase but had no effect on the activity of ornithine decarboxylase and nitric oxide synthase in serum, and these responses were the same at the gene expression level in mammary gland. In addition, the infusion of nor-NOHA also reduced protein and fat synthesis in milk but had no effect on milk yield. When Arg was infused with nor-NOHA, the activity of total arginase, ornithine decarboxylase, and nitric oxide synthase, and the concentration of casein, protein, and fat in milk did not change compared with the nor-NOHA group, but the milk protein yield, the expression of some Arg transporters (SLC7A5 and SLC7A8), and milk yield increased. Overall, results verified previous in vitro findings indicating that synthesis of casein protein is closely regulated by the Arg-ornithine pathway in bovine mammary gland.
Collapse
Affiliation(s)
- L Y Ding
- College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, P. R. China
| | - L M Chen
- College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, P. R. China
| | - M Z Wang
- College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, P. R. China.
| | - J Zhang
- The Experimental Farm of Yangzhou University, Yangzhou 225009, P. R. China.
| | - J J Loor
- Department of Animal Sciences and Division of Nutritional Sciences, University of Illinois, Urbana 61801
| | - G Zhou
- College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, P. R. China
| | - X Zhang
- College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, P. R. China
| | - H R Wang
- College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, P. R. China
| |
Collapse
|
5
|
Rodríguez-Gómez I, Moliz JN, Quesada A, Montoro-Molina S, Vargas-Tendero P, Osuna A, Wangensteen R, Vargas F. L-Arginine metabolism in cardiovascular and renal tissue from hyper- and hypothyroid rats. Exp Biol Med (Maywood) 2015; 241:550-6. [PMID: 26674221 DOI: 10.1177/1535370215619042] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2015] [Accepted: 10/27/2015] [Indexed: 12/31/2022] Open
Abstract
This study assessed the effects of thyroid hormones on the enzymes involved in l-arginine metabolism and the metabolites generated by the different metabolic pathways. Compounds of l-arginine metabolism were measured in the kidney, heart, aorta, and liver of euthyroid, hyperthyroid, and hypothyroid rats after 6 weeks of treatment. Enzymes studied were NOS isoforms (neuronal [nNOS], inducible [iNOS], and endothelial [eNOS]), arginases I and II, ornithine decarboxylase (ODC), ornithine aminotransferase (OAT), and l-arginine decarboxylase (ADC). Metabolites studied were l-arginine, l-citrulline, spermidine, spermine, and l-proline. Kidney heart and aorta levels of eNOS and iNOS were augmented and reduced (P < 0.05, for each tissue and enzyme) in hyper- and hypothyroid rats, respectively. Arginase I abundance in aorta, heart, and kidney was increased (P < 0.05, for each tissue) in hyperthyroid rats and was decreased in kidney and aorta of hypothyroid rats (P < 0.05, for each tissue). Arginase II was augmented in aorta and kidney (P < 0.05, for each tissue) of hyperthyroid rats and remained unchanged in all organs of hypothyroid rats. The substrate for these enzymes, l-arginine, was reduced (P < 0.05, for all tissues) in hyperthyroid rats. Levels of ODC and spermidine, its product, were increased and decreased (P < 0.05) in hyper- and hypothyroid rats, respectively, in all organs studied. OAT and proline levels were positively modulated by thyroid hormones in liver but not in the other tissues. ADC protein levels were positively modulated by thyroid hormones in all tissues. According to these findings, thyroid hormone treatment positively modulates different l-arginine metabolic pathways. The changes recorded in the abundance of eNOS, arginases I and II, and ADC protein in renal and cardiovascular tissues may play a role in the hemodynamic and renal manifestations observed in thyroid disorders. Furthermore, the changes in ODC and spermidine might contribute to the changes in cardiac and renal mass observed in thyroid disorders.
Collapse
Affiliation(s)
- Isabel Rodríguez-Gómez
- Instituto de Investigación Biosanitaria ibs. Granada 18012, Spain. Hospitales Universitarios de Granada. Universidad de Granada, Granada 18012, Spain
| | - Juan N Moliz
- Departamento de Fisiología, Facultad de Medicina, Grenada 18012, Spain
| | - Andrés Quesada
- Centro de Instrumentación Científica de la Universidad de Granada, Granada 18003, Spain
| | | | - Pablo Vargas-Tendero
- Instituto de Investigación Biosanitaria ibs. Granada 18012, Spain. Hospitales Universitarios de Granada. Universidad de Granada, Granada 18012, Spain
| | - Antonio Osuna
- Instituto de Investigación Biosanitaria ibs. Granada 18012, Spain. Hospitales Universitarios de Granada. Universidad de Granada, Granada 18012, Spain
| | - Rosemary Wangensteen
- Centro de Instrumentación Científica de la Universidad de Granada, Granada 18003, Spain
| | - Félix Vargas
- Instituto de Investigación Biosanitaria ibs. Granada 18012, Spain. Hospitales Universitarios de Granada. Universidad de Granada, Granada 18012, Spain
| |
Collapse
|